📢 Patients & clinicians—your voice matters!
Cambridge researchers need more diverse insights on APS, autoimmune diseases & hormonal health.
🔗 Patients: https://t.co/c3EzAelIID
🔗 Clinicians: https://t.co/WBlOfhxyIS
🎉 £200 prize draw (x2 per survey!)
#APSResearch#Autoimmune
Happy International Women's Day! Tag a woman who inspires you and tell us why 👇 #IWD2023
Social media can be used for good and that's why we created the campaign #DisruptYourFeed. ✊
If you experience a sign or symptom of DVT or PE, see immediate medical attention, even if you do not have any risk factors. You are the best advocate for your own health. Learn more about the signs and symptoms here: https://t.co/HmU8Wn0Gxd
#WTDay22#WorldThrombosisDay
With underwriting standards tightening, it's crucial for #renewableenergy project owners to adopt mature #riskmanagement strategies. Here's how to strengthen your contractual risk programs:
https://t.co/FHohPLripv
Marsh has experienced an acceleration in the volume of #ESG inquiries and conversations it is having with clients and insurance companies. Marsh's Amy Barnes spoke to Insurance Business UK about how ESG factors are changing the conversation.
https://t.co/vOB1GABQiV
Have you heard about the new anticoagulants on the market? They may sound promising, however, NONE of them have been approved for #APS patients. Studies completed so far show that APS patients are clotting on them but studies are in the works, though. In the meantime,
We are delighted to have Moses Ojeisekhoba CEO Reinsurance at @SwissRe, speaking and sharing his insights at (Re)Connect this September 6-9. View the agenda, speaker list and register online today: https://t.co/2gIaDEnEsb
#InsiderReConnect#insurance#reinsurance
Could you help create a more supportive work environment for colleagues who’ve experienced a miscarriage? Check out our ‘Miscarriage and the Workplace’ resource for case studies, best practice suggestions and guidance on creating a pregnancy loss policy. https://t.co/3Nt8K6vyNN